Showing results (61-70 of 77) with videos related to
Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|February 21, 2013
Phase II clinical study of BC-3781, a pleuromutilin antibiotic, in treatment of patients with acute bacterial skin and skin structure infectionsW T Prince, Z Ivezic-Schoenfeld, C Lell, et al.Antimicrobial Agents and Chemotherapy|September 16, 1998
Treatment of community-acquired acute uncomplicated urinary tract infection with sparfloxacin versus ofloxacin. The Sparfloxacin Multi Center UUTI Study GroupD Henry, W Ellison, J Sullivan, et al.The Journal of Antimicrobial Chemotherapy|December 1, 1992
Development of new antibiotic resistance in methicillin-resistant but not methicillin-susceptible Staphylococcus aureusS J Wadsworth, K H Kim, V Satishchandran, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2001
Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristinP K Linden, R C Moellering, C A Wood, et al.Clinical Therapeutics|April 22, 1999
Comparison of sparfloxacin and clarithromycin in the treatment of acute bacterial maxillary sinusitis. Sparfloxacin Multicenter AMS Study GroupD C Henry, D J Moller, J Adelglass, et al.Clinical Therapeutics|June 11, 1999
Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infectionsB A Lipsky, B Miller, R Schwartz, et al.Surgery, Gynecology & Obstetrics|August 1, 1990
A survey of exposures, practices and recommendations of surgeons in the care of patients with human immunodeficiency virusD A Mandelbrot, W R Smythe, S A Norman, et al.Clinical Therapeutics|January 7, 1998
Sparfloxacin versus cefaclor in the treatment of patients with community-acquired pneumonia: a randomized, double-masked, comparative, multicenter studyG R Donowitz, M L Brandon, J P Salisbury, et al.Annals of Internal Medicine|December 1, 1987
What is the cost of nephrotoxicity associated with aminoglycosides?J M Eisenberg, H Koffer, H A Glick, et al.Clinical Therapeutics|August 10, 1999
Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. Sparfloxacin Multicenter Uncomplicated Urinary Tract Infection Study GroupD C Henry, R C Nenad, A Iravani, et al.Pageof 8